Neuropsychological deficits associated with driving performance in Parkinson's and Alzheimer's disease

被引:120
作者
Grace, J
Amick, MM
D'Abreu, A
Festa, EK
Heindel, WC
Ott, BR
机构
[1] Brown Univ, Dept Psychiat & Human Behav, Providence, RI 02912 USA
[2] Brown Univ, Dept Clin Neurosci, Providence, RI USA
[3] Brown Univ, Dept Psychol, Providence, RI 02912 USA
关键词
dementia; motor vehicles; cognition; memory; neurodegenerative diseases; basal ganglia;
D O I
10.1017/S135561770505848
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Neuropsychological and motor deficits in Parkinson's disease that may contribute to driving impairment were examined in a cohort study comparing patients with Parkinson's disease (PD) to patients with Alzheimer's disease (AD) and to healthy elderly controls. Nondemented individuals with Parkinson's disease [Hoehn & Yahr (H&Y) stage I-III], patients with Alzheimer's disease [Clinical Demetia Rating scale (CDR) range 0-1], and elderly controls, who were actively driving, completed a neuropsychological battery and a standardized road test administered by a professional driving instructor. On-road driving ability was rated on number of driving errors and a global rating of safe, marginal, or unsafe. Overall, Alzheimer's patients were more impaired drivers than Parkinson's patients. Parkinson's patients distinguished themselves from other drivers by a head-turning deficiency. Drivers with neuropsychological impairment were more likely to be unsafe drivers in both disease groups compared to controls. Compared to controls, unsafe drivers with Alzheimer's disease were impaired across all neuropsychological measures except finger tapping. Driving performance in Parkinson's patients was related to disease severity (H&Y), neuropsychological measures [Rey Osterreith Complex Figure (ROCF), Trails B, Hopkins Verbal List Learning Test (HVLT)-delay.], and specific motor symptoms (axial rigidity, postural instability), but not to the Unified Parkinson Disease Rating Scale (UPDRS) motor score. Multifactorial measures (ROCF, Trails B) were useful in distinguishing safe from unsafe drivers in both patient groups.
引用
收藏
页码:766 / 775
页数:10
相关论文
共 50 条
  • [31] Cognitive deficits in Parkinson's disease
    Dubois, B
    Pillon, B
    JOURNAL OF NEUROLOGY, 1997, 244 (01) : 2 - 8
  • [32] Glycation in Parkinson's Disease and Alzheimer's Disease
    Vicente Miranda, Hugo
    El-Agnaf, Omar M. A.
    Outeiro, Tiago Fleming
    MOVEMENT DISORDERS, 2016, 31 (06) : 782 - 790
  • [33] Cognitive Deficits in Parkinson's Disease Are Associated with Neuronal Dysfunction and Not White Matter Lesions
    Schroeter, Nils
    Bormann, Tobias
    Rijntjes, Michel
    Blazhenets, Ganna
    Berti, Raissa
    Sajonz, Bastian E. A.
    Urbach, Horst
    Weiller, Cornelius
    Meyer, Philipp T.
    Rau, Alexander
    Frings, Lars
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2023, 10 (07): : 1066 - 1073
  • [34] Dopaminergic deficits along the spectrum of Alzheimer's disease
    Pilotto, Andrea
    Galli, Alice
    Sala, Arianna
    Caminiti, Silvia Paola
    Presotto, Luca
    Liguori, Claudio
    Mercuri, Nicola Biagio
    Premi, Enrico
    Garibotto, Valentina
    Frisoni, Giovanni
    Chiaravalloti, Agostino
    Schillaci, Orazio
    D'Amelio, Marcello
    Paghera, Barbara
    Lucchini, Silvia
    Bertagna, Francesco
    Perani, Daniela
    Padovani, Alessandro
    MOLECULAR PSYCHIATRY, 2025,
  • [35] Cognitive aspects of attention deficits in Alzheimer's disease
    Sieroff, Eric
    Joly, Charlotte
    Lenoir, Henri
    GERIATRIE ET PSYCHOLOGIE NEUROPSYCHIATRIE DE VIEILLISSEMENT, 2020, 18 (04): : 419 - 428
  • [36] Odor Identification Deficits Identify Parkinson's Disease Patients with Poor Cognitive Performance
    Damholdt, Malene Flensborg
    Borghammer, Per
    Larsen, Lars
    Ostergaard, Karen
    MOVEMENT DISORDERS, 2011, 26 (11) : 2045 - 2050
  • [37] Modulating brain networks associated with cognitive deficits in Parkinson’s disease
    Iman Beheshti
    Ji Hyun Ko
    Molecular Medicine, 2021, 27
  • [38] Modulating brain networks associated with cognitive deficits in Parkinson's disease
    Beheshti, Iman
    Ko, Ji Hyun
    MOLECULAR MEDICINE, 2021, 27 (01)
  • [39] Visuospatial Deficits Are Associated with Pisa Syndrome and not Camptocormia in Parkinson's Disease
    Artusi, Carlo Alberto
    Montanaro, Elisa
    Erro, Roberto
    Margraf, Nils
    Geroin, Christian
    Pilotto, Andrea
    Magistrelli, Luca
    Spagnolo, Francesca
    Marchet, Alberto
    Sarro, Lidia
    Cuoco, Sofia
    Sacchetti, Marta
    Riello, Marianna
    Capellero, Barbara
    Berchialla, Paola
    Moeller, Bettina
    Vullriede, Beeke
    Zibetti, Maurizio
    Rini, Augusto Maria
    Barone, Paolo
    Comi, Cristoforo
    Padovani, Alessandro
    Tinazzi, Michele
    Lopiano, Leonardo
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2023, 10 (01): : 64 - 73
  • [40] Effects of acute tryptophan depletion on neuropsychological and motor function in Parkinson's disease
    Mace, J. L.
    Porter, R. J.
    Dalrymple-Alford, J. C.
    Wesnes, K. A.
    Anderson, T. J.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2010, 24 (10) : 1465 - 1472